Advancing Diabetic Vision Care: Dr. Novack at the Mary Tyler Moore Vision Initiative

Ann Arbor November 2025 Dr. Novack attended the Mary Tyler Moore Vision Initiative https://www.marytylermoore.org/ annul meeting in November in Ann Arbor/Ypsilanti Michigan. There, he joined with a diverse group of vision scientists, ophthalmologists, and developers in a collegial, integrative approach to reducing diabetic vision loss. 

Dr. Novack at the Mary Tyler Moore Vision Initiative Annual Meeting in Ann Arbor, collaborating with leaders in ophthalmology and vision science to help reduce diabetic vision loss.

About Dr. Novack

Dr. Gary Novack is a board-certified clinical pharmacologist and President of PharmaLogic Development with more than 40 years of experience in ophthalmic drug development, clinical research, and FDA regulatory strategy.

He has consulted for over 100 pharmaceutical and medical device companies and authored more than 400 scientific publications.

Contact Dr. Novack
Contact Dr. Novack